Banner Photo_edited_edited.jpg

Beyond our medicines, lives

ABOUT

Ethypharm‌ ‌is a‌ ‌leading‌ ‌specialty‌ ‌pharmaceutical‌ ‌company‌ ‌with‌ ‌a‌ ‌strong‌ ‌heritage,‌ ‌based‌ ‌in‌ ‌the‌ ‌UK.‌ ‌


Ethypharm‌ ‌acquired‌ ‌Martindale‌ ‌Pharma‌ ‌in‌ ‌January‌ ‌2017‌ creating‌ ‌its‌ ‌position‌ ‌as‌ ‌a‌ ‌leading‌ ‌UK-based‌ ‌specialty‌ pharmaceutical‌ ‌company‌ ‌providing‌ ‌value‌ ‌adding‌ pharmaceutical‌ ‌products‌ ‌to‌ ‌over‌ ‌80‌ ‌countries‌ ‌around‌ ‌the‌ ‌world.‌ ‌

 

We‌ ‌have‌ ‌developed‌ ‌a‌ ‌comprehensive‌ ‌range‌ ‌of‌ ‌medicines‌ ‌to‌ ‌support‌ ‌an‌ ‌individual’s‌ ‌recovery‌ ‌from‌ ‌opioid‌ ‌addiction.‌ ‌Our‌ ‌products‌ ‌include‌ ‌formulations‌ ‌of‌ ‌the‌ ‌three‌ ‌standard‌ ‌molecules‌ ‌in‌ ‌this‌ ‌therapy‌ ‌area;‌ ‌methadone,‌ ‌buprenorphine‌ ‌and‌ ‌naloxone.‌ ‌

 

It‌ ‌is‌ ‌this‌ ‌depth‌ ‌of‌ ‌expertise‌ ‌that‌ ‌makes‌ ‌us‌ ‌a‌ ‌market‌ ‌leader‌ ‌and‌ ‌a‌ ‌trusted‌ ‌supplier‌ ‌of‌ ‌opioid‌ ‌addiction‌ ‌products.‌

 

If you would like to discuss how our budget impact model can help manage your prescribing costs please email info@ethypharm.com or for further information on our products visit www.ethypharm.co.uk

UK-GP-22

Date of preparation:  August 2020

Thank you for submitting an enquiry. We will respond as soon as possible.

If you would like to receive any information on our products then please complete the form below:

 

Please note, Ethypharm have provided sponsorship of this event but provided no input into the programme.

The views and opinions of the speakers are not necessarily those of Ethypharm.